ATE104355T1 - Nachweis eines mit atmungskrankheiten verbundenen einzelstammes von chlamydia. - Google Patents

Nachweis eines mit atmungskrankheiten verbundenen einzelstammes von chlamydia.

Info

Publication number
ATE104355T1
ATE104355T1 AT87903197T AT87903197T ATE104355T1 AT E104355 T1 ATE104355 T1 AT E104355T1 AT 87903197 T AT87903197 T AT 87903197T AT 87903197 T AT87903197 T AT 87903197T AT E104355 T1 ATE104355 T1 AT E104355T1
Authority
AT
Austria
Prior art keywords
chlamydia
linked
detection
respiratory diseases
twar organism
Prior art date
Application number
AT87903197T
Other languages
English (en)
Inventor
J Thomas Grayston
Cho-Chou Kuo
San-Pin Wang
Lee Ann Campbell
Original Assignee
Washington Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25328168&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE104355(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Washington Res Found filed Critical Washington Res Found
Application granted granted Critical
Publication of ATE104355T1 publication Critical patent/ATE104355T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/125—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Chlamydiales (O)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT87903197T 1986-05-01 1987-05-01 Nachweis eines mit atmungskrankheiten verbundenen einzelstammes von chlamydia. ATE104355T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85838086A 1986-05-01 1986-05-01
PCT/US1987/001011 WO1987006617A2 (en) 1986-05-01 1987-05-01 Detection of a unique chlamydia strain associated with acute respiratory disease
EP87903197A EP0264434B2 (de) 1986-05-01 1987-05-01 Nachweis eines mit atmungskrankheiten verbundenen einzelstammes von chlamydia

Publications (1)

Publication Number Publication Date
ATE104355T1 true ATE104355T1 (de) 1994-04-15

Family

ID=25328168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87903197T ATE104355T1 (de) 1986-05-01 1987-05-01 Nachweis eines mit atmungskrankheiten verbundenen einzelstammes von chlamydia.

Country Status (7)

Country Link
EP (2) EP0264434B2 (de)
JP (3) JP2675564B2 (de)
AT (1) ATE104355T1 (de)
CA (1) CA1341065C (de)
DE (1) DE3789597T3 (de)
ES (1) ES2005569A6 (de)
WO (1) WO1987006617A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2249892A (en) * 1991-06-14 1993-01-12 Board Of Regents Of The University Of Washington, The Diagnosis and treatment of arterial chlamydial granuloma
EP2045261A1 (de) 1994-09-20 2009-04-08 Hitachi Chemical Co., Ltd. Chlamydia pneumoniae antigene Polypeptide
US6210876B1 (en) 1996-06-06 2001-04-03 Abbott Laboratories Nucleic acid primers and probes for detecting Chlamydia pneumoniae
CA2338989C (en) * 1998-07-31 2010-07-27 Asahi Kasei Kogyo Kabushiki Kaisha Antibodies for detecting microorganisms
AU2006254891B2 (en) * 2005-06-06 2011-04-14 Gen-Probe Incorporated Compositions, methods and kits for determining the presence of Chlamydophila pneumoniae in a test sample
JP2022535747A (ja) * 2019-05-28 2022-08-10 ケース ウエスタン リザーブ ユニバーシティ Ｄｎａのメチル化を保存するための組成物および方法
AU2021281223A1 (en) 2020-05-27 2023-01-05 Case Western Reserve University Compositions and methods for preserving DNA methylation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO841725L (no) * 1983-05-02 1984-11-05 Enzo Biochem Inc Fremgangsmaate og stoffer til bruk ved analyse og paavisning av genetisk materiale
EP0168422A1 (de) * 1983-12-12 1986-01-22 Meru, Inc. Verfahren und materialien zum nachweis von mikroorganismen erzeugenden liposacchariden
FI71768C (fi) * 1984-02-17 1987-02-09 Orion Yhtymae Oy Foerbaettrade nykleinsyrareagenser och foerfarande foer deras framstaellning.
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies

Also Published As

Publication number Publication date
JPH09285288A (ja) 1997-11-04
EP0577144A1 (de) 1994-01-05
WO1987006617A3 (en) 1988-04-07
JPH11123077A (ja) 1999-05-11
WO1987006617A2 (en) 1987-11-05
DE3789597T3 (de) 2006-10-26
AU7390687A (en) 1987-11-24
EP0264434B2 (de) 2006-02-01
EP0264434A1 (de) 1988-04-27
CA1341065C (en) 2000-08-01
EP0264434B1 (de) 1994-04-13
DE3789597D1 (de) 1994-05-19
JPH01500083A (ja) 1989-01-19
DE3789597T2 (de) 1994-07-21
ES2005569A6 (es) 1989-03-16
AU605485B2 (en) 1991-01-17
JP2675564B2 (ja) 1997-11-12

Similar Documents

Publication Publication Date Title
ES2094733T3 (es) Deteccion de enfermedades o disfunciones neurologicas.
RU93058563A (ru) Полипептиды, иммунореагент, способ определения антител, способ индукции иммунного ответа, композиции, способ получения полипептида
ATE130681T1 (de) Bestimmung eines felinen pathogen-specifischen antikörpers und eines felinen pathogenen antigens in einem immuntest.
Losonsky et al. Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers
ATE15945T1 (de) Verfahren zum nachweis von haemoglobin in faezes.
DE3886265D1 (de) Anti-FR-900506-Stoffe-Antikörper und höchstempfindliches Enzym-Immunoassay-Verfahren.
ATE161288T1 (de) Monoklonaler antikörper gegen enterohämorrhagische escherichia coli o157:h7 und 026:h11 sowie nachweisverfahren
NZ230148A (en) Ibd (infectious bursal disease) monoclonal antibody vaccines, immunised chicks and a method of assaying for ibd
ATE157774T1 (de) Verfahren zum nachweis der alzheimer-krankheit
ATE184704T1 (de) Nachweismethode für harnkarzinom-assoziierte antigene
Jemmerson et al. Mapping antigenic sites on proteins: Implications for the design of synthetic vaccines.
ATE104355T1 (de) Nachweis eines mit atmungskrankheiten verbundenen einzelstammes von chlamydia.
DE3069404D1 (en) Radioimmunoassay of migration inhibitory factor
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
JPS6428560A (en) Immunometric measurement
DE3587542D1 (de) Verfahren zur Diagnose in vitro von menschlichen Cytomegalovirusinfektionen und Anwendung von monoklonalen Antikörpern gegen Cytomegaloviren, die mit einer cytomegalovirusinduzierten Proteinkinase reagieren.
DK0418590T3 (da) Antistoffer, fremstilling deraf og anvendelse deraf
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
NO174153C (no) Antigen og monoklonalt antistoff for anvendelse in vitro, samt immunologiske reagenser inneholdende disse
Coe Immune response in the turtle (Chrysemys picta)
DE3781721D1 (de) Verfahren zur herstellung eines immunreaktiven traegermaterials fuer die heterogene immunologische analyse.
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
DE3850692D1 (de) Treponema hyodysenteriae-Antigen und seine Verwendungen.
Schmeer Answer to the commentary of Dr. Heyermann
Ji et al. A rapid, simple method for detecting the virulence of Shigella and EIEC strains by ELISA.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0264434

Country of ref document: EP

EELA Cancelled due to lapse of time